A pharmaceutical executive unexpectedly collapsed in the Oval Office today during a press briefing. The incident occurred while the man was standing behind the US president as the Trump administration unveiled a new agreement for weight-loss medications, causing his knees to give out suddenly.
Upon witnessing the collapse, administration officials and pharmaceutical representatives swiftly rushed to assist the individual, preventing him from falling to the ground. White House Press Secretary Karoline Leavitt clarified that during the ‘Most Favored Nations Oval Office Announcement’, a representative from one of the companies attending the event had fainted.
Leavitt reassured that medical personnel on-site promptly attended to the individual, confirming his well-being. She further stated that the press conference would resume shortly, issuing a statement that read: “During the Most Favored Nations Oval Office Announcement, a representative with one of the companies fainted. The White House Medical Unit quickly jumped into action, and the gentleman is okay. The Press Conference will resume shortly.”
Following the incident, reporters were escorted out of the Oval Office while cabinet members provided aid to the individual, elevating his legs. The cause of the collapse remains unidentified.
The press conference featured executives from pharmaceutical giants Novo Nordisk and Eli Lilly standing together with the Trump administration to introduce a groundbreaking deal that could significantly impact the healthcare industry. The agreement entails the availability of popular treatments such as Ozempic, Wegovy, and Zepbound directly to the public through TrumpRx, a forthcoming government website.
As part of the initiative, the companies aim to offer an oral version of the medications for approximately $149 (£113) per month pending FDA approval. Additionally, individuals covered by Medicare or Medicaid and dealing with conditions like diabetes will benefit from reduced prices of the injectable versions, costing $245 (£186) per month.
Receive email updates with the top news stories of the day.
